Evidence map›Paper›PMID 38300317›Full record

ReviewArchives of microbiology2024

Understanding the intricacies of microbial biofilm formation and its endurance in chronic infections: a key to advancing biofilm-targeted therapeutic strategies.

Freeda Princy Dsouza, Susha Dinesh, Sameer Sharma

Abstract readReview
PubMed Publisher
In one paragraph

Review in Archives of microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
11.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 47 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. A critical role ofPNAS nexus · 2026
    Article
  7. Article
  8. Review
  9. Antibiotics (Basel, Switzerland) · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Microorganisms · 2025
    Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Effects of Curcumin on Biofilm Production and Associated Gene in Multidrug-ResistantInternational journal of molecular and cellular medicine · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Freeda Princy DsouzaDepartment of Bioinformatics, BioNome, Bengaluru, Karnataka, 560043, India.ORCID http://orcid.org/0009-0002-2589-7830
Susha DineshDepartment of Bioinformatics, BioNome, Bengaluru, Karnataka, 560043, India. susha@bionome.in.ORCID http://orcid.org/0000-0001-6593-3803
Sameer SharmaDepartment of Bioinformatics, BioNome, Bengaluru, Karnataka, 560043, India.ORCID http://orcid.org/0000-0002-3456-0263
Institute of Bioinformatics · IN

Funding

Department of Scientific Research and Education, BioNome DSRE/BNM/SR/2023/A0116
6 · The paper itself

Abstract

Bacterial biofilms can adhere to various surfaces in the environment with human beings being no exception. Enclosed in a self-secreted matrix which contains extracellular polymeric substances, biofilms are intricate communities of bacteria that play a significant role across various sectors and raise concerns for public health, medicine and industries. These complex structures allow free-floating planktonic cells to adopt multicellular mode of growth which leads to persistent infections. This is of great concern as biofilms can withstand external attacks which include antibiotics and immune responses. A more comprehensive and innovative approach to therapy is needed in view of the increasing issue of bacterial resistance brought on by the overuse of conventional antimicrobial medications. Thus, to oppose the challenges posed by biofilm-related infections, innovative therapeutic strategies are being explored which include targeting extracellular polymeric substances, quorum sensing, and persister cells. Biofilm-responsive nanoparticles show promising results by improving drug delivery and reducing the side effects. This review comprehensively examines the factors influencing biofilm formation, host immune defence mechanisms, infections caused by biofilms, diagnostic approaches, and biofilm-targeted therapies.

Indexed as

BiofilmsPersistent InfectionAnti-Bacterial AgentsBiological TransportHumansQuorum SensingAnti-Bacterial AgentsAntibodiesBiofilmBiofilm formationEPSQuorum sensing

Identifiers

PMID38300317
OpenAlexW4391446147

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.